Catalyst Wire Dossier Catalyst Wire Dossier

sebretalstat

sebretalstat · KalVista Pharmaceuticals, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sebretalstat, covering 2026-08-05 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II [Phase 3]

See pricing